(S)-2-(3,4,5-Trimethoxyphenyl)butanoic acid, 95.0%, 100mg

Isopropyl Cyclohexanecarboxylate>98.0%(GC)25mL

tert-Butyl 7-(benzyloxy)-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylate, 98%, 100mg

2-([1,1'-Biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine>98.0%(HPLC)(N)5g

(3-Bromo-2-ethoxy-5-fluorophenyl)boronic acid, 95%, 1g

(1s,4s)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclohexanecarboxylic acid, 99.0%, 10g

(E)-5-Styrylbenzene-1,3-diol, 1g

(4-Methylpent-1-en-1-yl)boronic acid, 95.0%, 100mg

N-(tert-Butyl)-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 97%, 250mg

Cresyl Diphenyl Phosphate (mixture of analogue)500mL

(R)-1,1,1-Trifluoropropan-2-ol, 98%, 25g

N-benzyl-6-chloropyridazin-3-amine, 95.0%, 250mg

GC capillary column ROTI®Cap-1, 25 m, 0.32 mm, 0.10 µm, 1 Piece(s)